EyePoint Pharmaceuticals, Inc. (EYPT) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 64 Form 4 transactions for EyePoint Pharmaceuticals, Inc. (EYPT) over the past 18 months (most recent 2026-08-24). Recent activity: Elston George (Chief Financial Officer) Sell 5,000 shares, Elston George (Chief Financial Officer) Buy 5,000 shares, Elston George (Chief Financial Officer) Sell 64,953 shares, Elston George (Chief Financial Officer) Buy 64,953 shares, Zaderej Karen L. (Director) Buy 10,600 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-24Elston GeorgeChief Financial OfficerSell5,000$0
2026-08-24Elston GeorgeChief Financial OfficerBuy5,000$0
2026-08-24Elston GeorgeChief Financial OfficerSell64,953$0
2026-08-24Elston GeorgeChief Financial OfficerBuy64,953$0
2026-08-18Zaderej Karen L.DirectorBuy10,600$52,258
2026-07-14Duker Jay S.President and CEOBuy16,667$0
2026-07-14Duker Jay S.President and CEOSell8,059$118,628
2026-07-02Ribeiro RamiroChief Medical OfficerBuy2,437$20,130
2026-07-02Ribeiro RamiroChief Medical OfficerBuy2,438$20,138
2026-07-02Ribeiro RamiroChief Medical OfficerSell2,437$36,555
2026-07-02Ribeiro RamiroChief Medical OfficerSell2,438$36,612
2026-05-27Elston GeorgeChief Financial OfficerSell3,627$46,897
2026-05-27Elston GeorgeChief Financial OfficerBuy7,500$0
2026-04-20Ribeiro RamiroChief Medical OfficerBuy2,437$20,130
2026-04-20Ribeiro RamiroChief Medical OfficerSell2,437$36,555
2026-03-24Duker Jay S.President and CEOSell76,766$1.0M
2026-03-24Duker Jay S.President and CEOBuy76,766$1.0M
2026-03-16Duker Jay S.President and CEOBuy1,500$19,725
2026-03-06Elston GeorgeChief Financial OfficerSell5,000$0
2026-03-06Elston GeorgeChief Financial OfficerBuy5,000$0
2026-03-05Ribeiro RamiroChief Medical OfficerBuy2,438$20,138
2026-03-05Ribeiro RamiroChief Medical OfficerSell2,438$43,567
2026-02-18Ribeiro RamiroChief Medical OfficerBuy2,437$20,130
2026-02-18Ribeiro RamiroChief Medical OfficerSell2,437$36,555
2026-01-07Duker Jay S.President and CEOBuy20,793$0

Source: SEC Form 4 filings · as of 2026-08-24